Champions Oncology IncCSBR
Price$4.88Intrinsic value$6.6837% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $60.7M+6.5% YoYTTM through 31 Jul 2026
Net Income -$1.1M-124.1% YoYTTM through 31 Jul 2026
Free Cash Flow -$6.1MTTM through 31 Jul 2026

Margins

Current
Gross Margin47.0%
EBITDA Margin0.6%
Operating Margin-16.6%
Net Margin-1.9%

Returns

-55.7%ROE
-8.6%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio0.98x
Net Debt-$7.1Mnet cash position
Cash & Equivalents$4.4M

Quality Metrics

Altman Z-Score-0.15
Piotroski F-Score2 / 9
FCF Margin-10.1%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $59.4M
Diluted EPS-$0.08TTM
'20'21'22'23'24'25'26
FY2026: $-0.08

Dividend

No dividend

Capital Allocation

R&D Spend$9.3M
Capex Intensity0.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.